TXN
29
4
CMI
49
2
CTAS
36
8
ICE
53
5
ECL
54
5
HST
53
4
HCA
37
7
RRC
52
2
JPM
59
6
PVH
58
5
AIG
38
5
KIM
58
2
LNC
28
3
NTAP
58
3
A
43
2
EOG
28
2
SCHW
40
3
ADT
12
2
ABBV
40
5
PM
49
8
TXN
29
4
CMI
49
2
CTAS
36
8
ICE
53
5
ECL
54
5
HST
53
4
HCA
37
7
RRC
52
2
JPM
59
6
PVH
58
5
AIG
38
5
KIM
58
2
LNC
28
3
NTAP
58
3
A
43
2
EOG
28
2
SCHW
40
3
ADT
12
2
ABBV
40
5
PM
49
8
Financhill
Back

Evoke Pharma 10K Form

Buy
53

EVOK
Evoke Pharma

Last Price:
$5.02
Seasonality Move:
1.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-14 10Q EVOK/Evoke Pharma Quarterly
2023-11-09 10Q EVOK/Evoke Pharma Quarterly
2023-08-10 10Q EVOK/Evoke Pharma Quarterly
2023-05-15 10Q EVOK/Evoke Pharma Quarterly
2022-11-09 10Q EVOK/Evoke Pharma Quarterly
2022-08-10 10Q EVOK/Evoke Pharma Quarterly

Receive EVOK News And Ratings

See the #1 stock for the next 7 days that we like better than EVOK

EVOK Financial Statistics

Sales & Book Value

Annual Sales: $5.2M
Cash Flow: $-818.7K
Price / Cash Flow: 0
Annual Sales: $4.90
Price / Book: 1.72

Profitability

EPS (TTM): -11.03000
Net Income (TTM): $-6.1M
Gross Margin: $5M
Return on Equity: -433.12%
Return on Assets: -57.27%

Evoke Pharma Earnings Forecast

Key Evoke Pharma Financial Ratios

  • The Gross Profit Margin over the past 13 years for EVOK is 96.10%.
  • The Selling, General & Administrative Expenses for EVOK have been equal to 236.03% of Gross Profit Margin.
  • The Research & Development expenses have been 3.51% of Revenue.
  • The Interest Expense is -6.42% of Operating Income.
  • The Net Earning history of EVOK is -150.41% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 10 years.

Evoke Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: EVOK
CUSIP: 30049G
Website: evokepharma.com

Debt

Debt-to-Equity Ratio: 1.14
Current Ratio: 1.44
Quick Ratio: 1.37

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 10.6

EVOK Technical Analysis vs Fundamental Analysis

Buy
53
Evoke Pharma (EVOK) is a Buy

Is Evoke Pharma a Buy or a Sell?

  • Evoke Pharma stock is rated a Buy
    The current Evoke Pharma [EVOK] share price is $5.09. The Score for EVOK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.